BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24785146)

  • 21. UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib.
    Landmann H; Proia DA; He S; Ogawa LS; Kramer F; Beißbarth T; Grade M; Gaedcke J; Ghadimi M; Moll U; Dobbelstein M
    Cell Death Dis; 2014 Sep; 5(9):e1411. PubMed ID: 25210794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A molecular role for lysyl oxidase in breast cancer invasion.
    Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ
    Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1.
    Kim BR; Dong SM; Seo SH; Lee JH; Lee JM; Lee SH; Rho SB
    Cell Signal; 2014 Sep; 26(9):1765-73. PubMed ID: 24863880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation.
    Iftikhar M; Hurtado P; Bais MV; Wigner N; Stephens DN; Gerstenfeld LC; Trackman PC
    J Biol Chem; 2011 Jan; 286(2):909-18. PubMed ID: 21071451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells.
    Lee H; Saini N; Howard EW; Parris AB; Ma Z; Zhao Q; Zhao M; Liu B; Edgerton SM; Thor AD; Yang X
    Sci Rep; 2018 May; 8(1):6829. PubMed ID: 29717218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells.
    Hollosi P; Yakushiji JK; Fong KS; Csiszar K; Fong SF
    Int J Cancer; 2009 Jul; 125(2):318-27. PubMed ID: 19330836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X; Yu JJ
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy.
    Ying W; Du Z; Sun L; Foley KP; Proia DA; Blackman RK; Zhou D; Inoue T; Tatsuta N; Sang J; Ye S; Acquaviva J; Ogawa LS; Wada Y; Barsoum J; Koya K
    Mol Cancer Ther; 2012 Feb; 11(2):475-84. PubMed ID: 22144665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of lysyl oxidase-like 2 enzymatic activity by an allosteric antibody inhibitor.
    Rodriguez HM; Vaysberg M; Mikels A; McCauley S; Velayo AC; Garcia C; Smith V
    J Biol Chem; 2010 Jul; 285(27):20964-74. PubMed ID: 20439985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifaceted intervention by the Hsp90 inhibitor ganetespib (STA-9090) in cancer cells with activated JAK/STAT signaling.
    Proia DA; Foley KP; Korbut T; Sang J; Smith D; Bates RC; Liu Y; Rosenberg AF; Zhou D; Koya K; Barsoum J; Blackman RK
    PLoS One; 2011 Apr; 6(4):e18552. PubMed ID: 21533169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysyl oxidase-like 2 promotes esophageal squamous cell carcinoma cell migration independent of catalytic activity.
    Zou H; Wen B; Li RL; Zhan XH; Jiao JW; Liao LD; Wu BL; Xie WM; Xu LY; Li EM
    Int J Biochem Cell Biol; 2020 Aug; 125():105795. PubMed ID: 32580015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro.
    Moon HJ; Finney J; Xu L; Moore D; Welch DR; Mure M
    J Biol Chem; 2013 Oct; 288(42):30000-30008. PubMed ID: 24014025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.
    Wang C; Xu S; Tian Y; Ju A; Hou Q; Liu J; Fu Y; Luo Y
    Neoplasia; 2019 Apr; 21(4):413-427. PubMed ID: 30925417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human lysyl oxidase-like 2.
    Moon HJ; Finney J; Ronnebaum T; Mure M
    Bioorg Chem; 2014 Dec; 57():231-241. PubMed ID: 25146937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
    Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
    J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling.
    Lee H; Saini N; Parris AB; Zhao M; Yang X
    Int J Oncol; 2017 Sep; 51(3):967-974. PubMed ID: 28713919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
    Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
    J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes.
    Friedland JC; Smith DL; Sang J; Acquaviva J; He S; Zhang C; Proia DA
    Invest New Drugs; 2014 Feb; 32(1):14-24. PubMed ID: 23686707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma.
    Lv GQ; Zou HY; Liao LD; Cao HH; Zeng FM; Wu BL; Xie JJ; Fang WK; Xu LY; Li EM
    Biochem Cell Biol; 2014 Oct; 92(5):379-89. PubMed ID: 25275797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A truncated splice variant of human lysyl oxidase-like 2 promotes migration and invasion in esophageal squamous cell carcinoma.
    Zou HY; Lv GQ; Dai LH; Zhan XH; Jiao JW; Liao LD; Zhou TM; Li CQ; Wu BL; Xu LY; Li EM
    Int J Biochem Cell Biol; 2016 Jun; 75():85-98. PubMed ID: 27063404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.